UFPT
UFP Technologies, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth +15.4% ·
share flow -1.0% ·
net new positions +13.3%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | +1 | 2.97K | $872,497 | +1 | n/a |
| Q2 2026 | 83 | 0 | 5.59M | $1.48B | +5 | −6 |
| Q1 2026 | 87 | -2 | 5.05M | $977.88M | +5 | −7 |
| Q4 2025 | 89 | -3 | 5.34M | $1.19B | n/a | −3 |
| Q3 2025 | 18 | 0 | 2.83M | $564.24M | n/a | n/a |
| Q2 2025 | 15 | +2 | 2.67M | $652.20M | +2 | n/a |
| Q1 2025 | 10 | -1 | 1.10M | $222.08M | +1 | −2 |
| Q4 2024 | 11 | 0 | 1.06M | $258.43M | +1 | −1 |
| Q3 2024 | 10 | 0 | 609.62K | $193.08M | +1 | −1 |
| Q2 2024 | 10 | n/a | 642.12K | $169.45M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 1.07M | n/a | $261.91M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 2 | The Vanguard Group ✦ (passive) | 524.04K | n/a | $127.95M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 283.32K | 0.0% | $69.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 233.26K | -10.2% | $56.95M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 186.09K | +3.3% | $45.44M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | T. Rowe Price ✦ | 176.98K | +1.1% | $43.21M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 67.67K | -27.8% | $16.52M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 52.86K | +36.2% | $12.91M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | D. E. Shaw & Co. ✦ | 33.51K | +402.4% | $8.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 33.24K | -36.1% | $8.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 2.54K | -73.7% | $620,655 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 1.62K | n/a | $395,986 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 1.35K | -26.2% | $330,348 | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 14 | Point72 Asset Management ✦ | 1.12K | New | $272,891 | 0.0% | New | 1 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 855 | New | $208,757 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $272,891 | 0.0% |
| Gotham Asset Management | $208,757 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 271 holders, 8.76M shares, $1.58B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 3.65K sh · $1.11M
Director · 3.35K sh · $1.02M
Director · 298 sh · $95,095
Director · 1.93K sh · $625,141
Director · 1.00K sh · $324,260
Officer, Director · 374 sh · $118,659
Officer, Director · 6.87K sh · $2.17M
Officer, Director · 5.77K sh · $1.82M
Officer, Director · 542 sh · $170,763
Officer, Director · 4.47K sh · $1.42M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology